Skip to main content
Premium Trial:

Request an Annual Quote

Genomic Solutions and PerkinElmer Revise Distribution Deal: Now It s Nonexclusive


Genomic Solutions and PerkinElmer have once again redrawn the chalk lines of their distribution territories. This time, the Ann Arbor, Mich., maker of arraying and proteomics equipment gained some territory.

PerkinElmer, which formerly held the exclusive rights to distribute Genomic Solutions’ products outside the US and Japan, now has non-exclusive rights to do so. While losing exclusivity, Perkin-Elmer has gained the worldwide distribution rights to Genomic Solutions’ Investigator proteomic electrophoresis products and its GeneTac HybStation.

In the wake of Genomic Solutions Cartesian Technologies acquisition, which it completed in late December, the new agreement also gives PerkinElmer worldwide distribution rights to Cartesian Technologies products, except in cases where Cartesian has prior agreements with third parties that prevent additional distributors in that country.

The two companies have had a comprehensive sales, distribution, and technology alliance since December 1999, when PerkinElmer made an equity investment in the company. After settling a lawsuit regarding that equity stake in spring 2001, the firms expanded that arrangement.

This latest rearrangement comes not only after the Cartesian acquisition, but after PerkinElmer’s November acquisition of Packard Biosciences, which makes arraying equipment that competes with Genomic Solutions instruments and Cartesian’s arrayers.


The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.